Ramez Nairooz
Overview
Explore the profile of Ramez Nairooz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nairooz R, Parzynski C, Curtis J, Mohsen A, McNulty E, Uretsky B, et al.
Am J Cardiol
. 2020 Jul;
130:37-45.
PMID: 32665131
Coronary artery perforation (CP) is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). Given the marked increase in high-risk and complex PCIs, careful review and understanding of...
2.
Nairooz R, Saad M, Dhillon A, Yousaf H, Awar L, Mehra A, et al.
Cardiovasc Revasc Med
. 2018 Aug;
19(8):951-955.
PMID: 30078629
Background: The optimal stent for use in saphenous vein graft (SVG) intervention is still debatable. Multiple randomized trials have compared drug-eluting stents (DES) to bare metal stents (BMS) in SVG...
3.
Maskoun W, Pino M, Ayoub K, Llanos O, Almomani A, Nairooz R, et al.
JACC Clin Electrophysiol
. 2018 May;
2(6):682-690.
PMID: 29759746
Objectives: This study was conceived to perform a comprehensive systematic review and meta-analysis of the available evidence to compute the incidence of atrial fibrillation (AF) after successful atrial flutter (AFL)...
4.
Abdelaziz H, Saad M, Abuomara H, Nairooz R, Pothineni N, Madmani M, et al.
Catheter Cardiovasc Interv
. 2018 May;
92(1):176-186.
PMID: 29726616
Objectives: To examine long-term clinical outcomes with transcatheter patent foramen ovale (PFO) closure versus medical therapy alone in patients with cryptogenic stroke. Background: A long-standing debate regarding the optimal approach...
5.
Maskoun W, Saad M, Abualsuod A, Nairooz R, Miller J
Int J Cardiol
. 2018 Apr;
267:107-113.
PMID: 29655948
Background: Current ventricular tachycardia (VT) management in patients with ischemic cardiomyopathy (ICM) includes optimal medical therapy, ICDs device therapy, and antiarrhythmic medications. Data about outcomes of catheter ablation (CA) in...
6.
Saad M, Pothineni N, Thomas J, Parikh R, Kovelamudi S, Elsayed D, et al.
Curr Cardiol Rep
. 2018 Feb;
20(2):10.
PMID: 29435665
Purpose Of Review: This review aims to summarize the evidence and challenges of coronary artery calcium (CAC) scoring as a screening tool for coronary artery disease (CAD) in young adults....
7.
Saad M, Nairooz R, Pothineni N, Almomani A, Kovelamudi S, Sardar P, et al.
JACC Cardiovasc Interv
. 2017 Oct;
11(1):24-35.
PMID: 29055767
Objectives: This study sought to examine long-term outcomes with transcatheter aortic valve replacement (TAVR) in women versus men. Background: TAVR is commonly performed in women. Previous studies have shown conflicting...
8.
Sardar P, Chatterjee S, Aronow H, Kundu A, Ramchand P, Mukherjee D, et al.
J Am Coll Cardiol
. 2017 May;
69(18):2266-2275.
PMID: 28473130
Background: Data conflict regarding the relative effectiveness of carotid artery stenting (CAS) and carotid artery endarterectomy (CEA) for the prevention of stroke due to carotid artery stenosis. Objectives: The authors...
9.
Sardar P, Kundu A, Bischoff M, Chatterjee S, Owan T, Nairooz R, et al.
Catheter Cardiovasc Interv
. 2017 May;
91(2):203-212.
PMID: 28471093
Objectives: This meta-analysis evaluated the effectiveness of hybrid coronary revascularization (HCR) compared to coronary artery bypass grafting (CABG) for the treatment of multivessel coronary artery disease (MVCAD). Background: HCR involves...
10.
Sardar P, Giri J, Elmariah S, Chatterjee S, Kolte D, Kundu A, et al.
Am J Cardiol
. 2017 Apr;
119(11):1746-1752.
PMID: 28400029
Patients with unprotected left main coronary artery (ULMCA) disease are increasingly treated with percutaneous coronary intervention (PCI) using new-generation drug-eluting stents (DES); however, the benefits of DES compared with coronary...